Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Space Forge
Space Forge is a UK-based company specializing in in-space manufacturing, utilizing microgravity environments to produce ultra-high-quality semiconductor substrates for applications in power electronics, telecommunications, and quantum technologies. Their ForgeStar® platform offers rapid, reliable, and returnable vehicles to harness the unique conditions of space for material production.
- Sector: Information Technology
- Last known transaction date: Series A Venture, $30M, May 2025
- Why timing suggests a near-term transaction: A $30M Series A in May 2025 provides roughly 18–24 months of runway for a space technology company, where satellite manufacturing, launch costs, and mission development timelines drive elevated capital consumption relative to traditional IT peers — placing Space Forge in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate in-orbit manufacturing milestones and early commercial customer validation that growth-stage deep tech investors require.
View all private company data in Dakota Marketplace.
2. Reflect Orbital
Reflect Orbital is a private aerospace company specializing in delivering sunlight on demand by deploying a constellation of in-space mirrors. Their innovative technology aims to provide continuous lighting and energy solutions by reflecting sunlight to Earth, addressing challenges in energy resilience and nighttime illumination.
- Sector: Utilities
- Last known transaction date: Series A Venture, $20M, May 2025
- Why timing suggests a near-term transaction: A $20M Series A in May 2025 provides roughly 18–24 months of runway for a space-based utilities company, where satellite development, launch costs, and regulatory approvals for novel orbital infrastructure drive elevated burn rates — placing Reflect Orbital in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate technical feasibility, secure early offtake agreements, and build the commercial validation that deep tech infrastructure investors require to underwrite a larger round.
View all private company data in Dakota Marketplace.
3. Openlayer
Openlayer is a San Francisco-based company specializing in AI evaluation and observability, providing tools to help enterprises scale AI with confidence. Their platform focuses on detecting and eliminating failure patterns and biases in machine learning models, enabling developers to build reliable, performant, and ethical AI systems.
- Sector: Industrials
- Last known funding round: Series A Venture, $14.5M, May 2025
- Why timing suggests a near-term transaction: A $14.5M Series A in May 2025 provides roughly 18–24 months of runway for an industrials technology company, where enterprise sales cycles, integration complexity, and customer deployment costs drive steady capital consumption — placing Openlayer in the active fundraising window for a Series B by late 2026 to early 2027 as it looks to demonstrate enterprise customer traction, product scalability, and the recurring revenue growth that growth-stage industrial technology investors require.
View all private company data in Dakota Marketplace.
4. DiffuseDrive Inc.
DiffuseDrive Inc. is a developer tool company specializing in high-fidelity synthetic data generation for computer vision development. Founded in 2022 by Balint Pasztor and Roland Pinter, the company is headquartered in San Francisco, California. DiffuseDrive's mission is to streamline the data generation process for autonomous driving development by leveraging advanced generative AI technology. Their core product is an end-to-end automated data solution that enables the creation of photorealistic scenarios based on text input, thereby eliminating development bottlenecks. The company has been recognized for addressing the challenges of data scarcity in AI training, particularly in the context of physical AI applications. Recent developments include securing a $3.5 million seed funding round in May 2025, led by Outlander Fund I Archimedes and Presto Ventures, to scale their generative AI solutions for robotics.
- Sector: Industrials
- Last known funding round: Seed Venture, $3.5M, May 2025
- Why timing suggests a near-term transaction: A $3.5M seed round in May 2025 provides a lean 12–15 month runway for an industrials company, where hardware development, manufacturing partnerships, and enterprise customer validation drive elevated burn relative to software peers — suggesting DiffuseDrive is very likely already in active fundraising conversations for a Series A and could be seeking to close a round by mid-to-late 2026 before runway constraints become critical.
View all private company data in Dakota Marketplace.
5. Therini Bio
Therini Bio is a biotechnology company focused on developing immunotherapies for neuroinflammatory diseases caused by vascular dysfunction. Their innovative approach targets toxic fibrin deposits that trigger inflammation, aiming to halt chronic neuroinflammation and neuronal damage in conditions such as Alzheimer's Disease and Diabetic Macular Edema.
- Sector: Health Care
- Last known funding round: Series A Venture, $75M, May 2025
- Why timing suggests a near-term transaction: A $75M Series A in May 2025 is a substantial raise for a healthcare company, typically supporting 24–36 months of clinical-stage runway, but the scale of investment signals an aggressive pipeline advancement strategy with elevated burn across multiple clinical programs, regulatory activities, and platform development — positioning Therini Bio in the active fundraising window for a Series B by late 2026 to mid-2027 as key clinical data readouts and proof-of-concept milestones from the Series A period create the catalysts needed to attract larger growth-stage capital.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
